| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 531399 | G G Automotive G G Automotive Gears Ltd | 14-May-2026 | GG Automotive Gears Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve 1. To consider and approve Audited Financial Results long with Auditors Report for the quarter and year ended on 31st March 2026; 2. To approve compliant Statement of Assets and Liabilities for the quarter and year ended 31st March 2026; 3. To approve compliant Cash Flow Statement for the quarter and year ended 31st March 2026; 4. Any other business with the permission of Chair. |
| 531569 | Sanjiv.Parant. Sanjivani Paranteral Ltd | 14-May-2026 | Sanjivani Paranteral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve 1. To approve Audited Standalone and Consolidated Financial Results along with Audit Report for the Fourth Quarter and Financial Year Ended 31st March 2026 pursuant to Regulation 33 of the Listing Obligation and Disclosure Requirement 2015; 2. Any other matter with the permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director. |
| 531717 | Vidhi Specialty Vidhi Specialty Food Ingredients Ltd | 14-May-2026 | Vidhi Specialty Food Ingredients Ltd-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve In terms of Reg 29 of SEBI (LODR) 2015 as amended from time to time, we wish to inform you that the meeting of the Board of Directors of Co is scheduled to be held on Thursday, May 14, 2026 to inter-alia transact the following business: 1. To consider and approve the Annual Standalone & Consolidated Financial Statements of the Co for the FY ended March 31, 2026. 2. To consider and approve the Financial Results (Standalone & Consolidated) of the Co for the quarter and FY ended March 31, 2026 3. To consider any other business with the permission of Chair. pursuant to SEBI (pit) Reg, 2015, as amended from time to time, the trading window of the Co has been closed from 01.04.2026 and shall remain closed till 48 hours from the announcement/declaration of the Audited Financial results of the Co for the quarter and FY ended March 31, 2026. Accordingly, the trading window shall remain closed from Wednesday, 01.04.2026 till Saturday, 16.05.2026 (both days inclusive). |
| 531752 | Biogen Pharma Biogen Pharmachem Industries Ltd | 14-May-2026 | Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 14th May 2026 inter alia to consider following businesses: - 1.) Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2026 along with the Reports of the Auditors thereon. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. |
| 532038 | Emmsons Intl. Emmsons International Ltd | 14-May-2026 | Emmsons International Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve 1. The Audited Standalone and Consolidated Financial Results for the quarter and financial year ended on March, 31 2026; 2.To appoint Internal Auditor of the Company for the Financial Year 2026-27 on the recommendation of the Audit Committee of the Board and 3.Any other business with the permission of the Chair. |
| 532057 | Abhinav Capital Abhinav Capital Services Ltd | 14-May-2026 | Abhinav Capital Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve 1) To grant Leave of absence if any . 2) To approve the Minutes of the Last Board Meeting. 3) To Discuss & approve the Audited Financial Results of the Company for the 4th quarter and year ended on 31st March 2026. 4) To note the resolutions passed as circular resolutions. 5) Any other matters with the permission of Chair. |
| 532163 | Saregama India Saregama India Ltd | 14-May-2026 | Saregama India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Saregama India Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve the Annual Audited Financial Results of the Company (Standalone and Consolidated) for the quarter and Financial Year ended on 31st March 2026 as required under Regulation 33 of the SEBI Listing Regulations. |
| 532181 | G M D C Gujarat Mineral Development Corporation Ltd | 14-May-2026 | Gujarat Mineral Development Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Audited Annual Results and to recommend Dividend if any |
| 532432 | United Spirits United Spirits Ltd | 14-May-2026 | Final Dividend & Audited Results United Spirits Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve the audited financial results (Standalone and Consolidated) of the Company and recommend final dividend, if any, for the financial year ended 31St March 2026. |
| 532553 | Welspun Enterp Welspun Enterprises Ltd | 14-May-2026 | Final Dividend & Audited Results Welspun Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve i) the audited standalone and consolidated financial results of the Company for the quarter and year ended March 31, 2026; ii) seek enabling approval from the members for:- a) raising funds through private placement of securities upto Rs. 1,000 Crore, in or more tranches; b) raising of funds by way of a private placement/preferential allotment/ qualified institutions placement and/or other permissible modes upto Rs. 1,000 Crore, in or more tranches; and iii) recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2026. |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
